Literature DB >> 23896971

AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition.

Benoit Chassaing1, Omry Koren2, Frederic A Carvalho3, Ruth E Ley2, Andrew T Gewirtz1.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) is driven by a seemingly aberrant immune response to the gut microbiota with disease development dictated by genetics and environmental factors. A model exemplifying this notion is our recent demonstration that colonisation of adherent-invasive Escherichia coli (AIEC) during microbiota acquisition drove chronic colitis in mice lacking the flagellin receptor TLR5 (T5KO). T5KO colitis persisted beyond AIEC clearance and requires TLR4 and the NLRC4 inflammasome. We hypothesised that AIEC instigates chronic inflammation by increasing microbial lipopolysaccharide (LPS) and flagellin levels. GOAL: Examine if transient AIEC colonisation lastingly alters levels of LPS and flagellin and changes microbiota composition.
METHODS: Germ-free mice (wild type (WT) and T5KO) were inoculated with AIEC strain LF82 and placed in standard housing allowing a complex microbiota that eliminated AIEC in both mice strains. Faeces were assayed for the inflammatory marker, lipocalin-2, bacterial loads, and microbiota composition by pyrosequencing. Faecal LPS and flagellin bioactivity were measured via a cell-based reporter assay.
RESULTS: Transient AIEC colonisation, in WT mice, did not alter inflammatory markers, bacterial loads, microbiota composition, nor its pro-inflammatory potential. By contrast, transient AIEC colonisation of T5KO mice drove chronic inflammation which correlated with microbiota components having higher levels of bioactive LPS and flagellin. Such AIEC-induced elevation of LPS and flagellin persisted well beyond AIEC clearance, required AIEC be flagellated, and was associated with alteration in microbiota species composition including a loss of species diversity.
CONCLUSIONS: AIEC, and perhaps other pathobionts, may instigate chronic inflammation in susceptible hosts by altering the gut microbiota composition so as to give it an inherently greater ability to activate innate immunity/pro-inflammatory gene expression. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  COLONIC MICROFLORA; CROHN'S DISEASE; INFLAMMATORY BOWEL DISEASE

Mesh:

Substances:

Year:  2013        PMID: 23896971      PMCID: PMC4089387          DOI: 10.1136/gutjnl-2013-304909

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  37 in total

1.  Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer.

Authors:  Helen M Martin; Barry J Campbell; C Anthony Hart; Chiedzo Mpofu; Manu Nayar; Ravinder Singh; Hans Englyst; Helen F Williams; Jonathan M Rhodes
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

2.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

3.  Diagnosis of multiple cancer types by shrunken centroids of gene expression.

Authors:  Robert Tibshirani; Trevor Hastie; Balasubramanian Narasimhan; Gilbert Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

4.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

5.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.

Authors:  S J Ott; M Musfeldt; D F Wenderoth; J Hampe; O Brant; U R Fölsch; K N Timmis; S Schreiber
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

6.  NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer.

Authors:  Aurélie Couturier-Maillard; Thomas Secher; Ateequr Rehman; Sylvain Normand; Adèle De Arcangelis; Robert Haesler; Ludovic Huot; Teddy Grandjean; Aude Bressenot; Anne Delanoye-Crespin; Olivier Gaillot; Stefan Schreiber; Yves Lemoine; Bernhard Ryffel; David Hot; Gabriel Nùñez; Grace Chen; Philip Rosenstiel; Mathias Chamaillard
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

7.  Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease.

Authors:  Nicolas Barnich; Jérôme Boudeau; Laurent Claret; Arlette Darfeuille-Michaud
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

8.  Bacterial flagellin is a dominant antigen in Crohn disease.

Authors:  Michael J Lodes; Yingzi Cong; Charles O Elson; Raodoh Mohamath; Carol J Landers; Stephan R Targan; Madeline Fort; Robert M Hershberg
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease.

Authors:  Arlette Darfeuille-Michaud; Jérôme Boudeau; Philippe Bulois; Christel Neut; Anne-Lise Glasser; Nicolas Barnich; Marie-Agnès Bringer; Alexander Swidsinski; Laurent Beaugerie; Jean-Frédéric Colombel
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

Review 10.  Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease.

Authors:  Arlette Darfeuille-Michaud
Journal:  Int J Med Microbiol       Date:  2002-09       Impact factor: 3.473

View more
  98 in total

Review 1.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 2.  Pathogenesis of Crohn's disease: Bug or no bug.

Authors:  Marta Maia Bosca-Watts; Joan Tosca; Rosario Anton; Maria Mora; Miguel Minguez; Francisco Mora
Journal:  World J Gastrointest Pathophysiol       Date:  2015-02-15

3.  Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis.

Authors:  Emilie Viennois; Didier Merlin; Andrew T Gewirtz; Benoit Chassaing
Journal:  Cancer Res       Date:  2016-11-07       Impact factor: 12.701

4.  Adherent-Invasive E. coli enhances colonic hypersensitivity and P2X receptors expression during post-infectious period.

Authors:  Amandine Lashermes; Ludivine Boudieu; Julie Barbier; Benoit Sion; Agathe Gelot; Nicolas Barnich; Denis Ardid; Frédéric Antonio Carvalho
Journal:  Gut Microbes       Date:  2017-10-04

Review 5.  Looking in the Porphyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer association.

Authors:  K R Atanasova; O Yilmaz
Journal:  Mol Oral Microbiol       Date:  2014-02-08       Impact factor: 3.563

Review 6.  Recent advances in adherence and invasion of pathogenic Escherichia coli.

Authors:  Anjana Kalita; Jia Hu; Alfredo G Torres
Journal:  Curr Opin Infect Dis       Date:  2014-10       Impact factor: 4.915

Review 7.  The first 1000 cultured species of the human gastrointestinal microbiota.

Authors:  Mirjana Rajilić-Stojanović; Willem M de Vos
Journal:  FEMS Microbiol Rev       Date:  2014-06-27       Impact factor: 16.408

Review 8.  Why related bacterial species bloom simultaneously in the gut: principles underlying the 'Like will to like' concept.

Authors:  Sebastian E Winter; Andreas J Bäumler
Journal:  Cell Microbiol       Date:  2013-12-16       Impact factor: 3.715

Review 9.  The role of the gut and microbes in the pathogenesis of spondyloarthritis.

Authors:  Mark Asquith; Dirk Elewaut; Phoebe Lin; James T Rosenbaum
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-11-15       Impact factor: 4.098

10.  Etiology of Diarrhea, Nutritional Outcomes, and Novel Intestinal Biomarkers in Tanzanian Infants.

Authors:  Kerri B Gosselin; Said Aboud; Christine M McDonald; Sabrina Moyo; Nasim Khavari; Karim Manji; Rodrick Kisenge; Wafaie Fawzi; Mark Kellogg; Hao Q Tran; Gibson Kibiki; Jean Gratz; Jie Liu; Andrew Gewirtz; Eric Houpt; Christopher Duggan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-01       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.